[go: up one dir, main page]

Miller et al., 2000 - Google Patents

Cysteine may play a role in the immune response to internal parasites in sheep

Miller et al., 2000

Document ID
1038203307108078764
Author
Miller F
Blair H
Birtles M
Reynolds G
Gill H
Revell D
Publication year
Publication venue
Australian Journal of Agricultural Research

External Links

Snippet

To investigate the potential role of cysteine in the increased parasite susceptibility of sheep selected for increased wool production, ten 2-year-old rams from both fleece-weight- selected (FW) and randomly selected (C) Romney lines received either 2 g of supplemental …
Continue reading at www.publish.csiro.au (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants

Similar Documents

Publication Publication Date Title
Rijkers et al. The immune system of cyprinid fish. The immunosuppressive effect of the antibiotic oxytetracycline in carp (Cyprinus carpio L.)
Daugschies et al. Eimeriosis in cattle: current understanding
Hanif et al. The effect of sea bream (Sparus aurata) broodstock and larval vaccination on the susceptibility by Photobacterium damsela subsp. piscicida and on the humoral immune parameters
Marcos‐López et al. Amoebic gill disease and host response in Atlantic salmon (Salmo salar L.): A review
MX2010012869A (en) Coccidiosis vaccines.
Zajac et al. Experimental Haemonchus contortus infection in three breeds of sheep
Ruiz et al. Immunization with Eimeria ninakohlyakimovae-live attenuated oocysts protect goat kids from clinical coccidiosis
Schwarz et al. Superinfection of sows with Cystoisospora suis ante partum leads to a milder course of cystoisosporosis in suckling piglets
Sukenda et al. The efficacy of Streptococcus agalactiae vaccine preparations, administered to tilapia broodstock, in preventing streptococcosis in their offspring, via transfer of maternal immunity
Miller et al. Cysteine may play a role in the immune response to internal parasites in sheep
Claerebout et al. The effect of different infection levels on acquired resistance to gastrointestinal nematodes in artificially infected cattle
Loa et al. Humoral and cellular immune responses in turkey poults infected with turkey coronavirus
Claerebout et al. Effects of preventive anthelmintic treatment on acquired resistance to gastrointestinal nematodes in naturally infected cattle
Stankiewicz et al. Drug-abbreviated infections and development of immunity against Trichostrongylus colubriformis in sheep
Biz et al. Effect of commercial tannins on parasitic infection and immunity of lambs naturally infected with Haemonchus contortus
Ziomko et al. Prevention of broiler chick coccidiosis using the inactivated subunit vaccine CoxAbic®
Claerebout et al. The effect of truncated infections with Ostertagia ostertagi on the development of acquired resistance in calves
Vercruysse et al. Control of gastrointestinal nematodes in first-season grazing calves by two strategic treatments with doramectin
Hodgson et al. Prophylactic use of human endotoxin-core hyperimmune gammaglobulin to prevent endotoxaemia in colostrum-deprived, gnotobiotic lambs challenged orally with Escherichia coli
Yousaf et al. Diagnosis and Treatment of Canine Babesiosis in a Female German Shepherd in Tandojam, Pakistan
Mauel Effector and escape mechanisms in host-parasite relationships
CA2517498A1 (en) Adjuvanted bovine vaccines
Herbert et al. Sarcocystosis
Morgan Section E. Diseases of dairy cattle. Brucellosis
Mahasri Effectivity Test Of Crude Protein Spore of Myxobolus koi as Materials Development For Sub Unit Vaccine To Prevent the Gold Fish (Cyprinus carpio, Linn) Dead by Myxobolusis